Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Roth

Showing results (751-760 of 940) with videos related to

Pageof 94
Sort By:
American Journal of Respiratory and Critical Care Medicine|November 4, 2017
Reliability and minimal clinically important differences of forced vital capacity: Results from the Scleroderma Lung Studies (SLS-I and SLS-II)Suzanne Kafaja, Philip J Clements, Holly Wilhalme, et al.
Arthritis Research & Therapy|December 26, 2015
Predictors of lung function decline in scleroderma-related interstitial lung disease based on high-resolution computed tomography: implications for cohort enrichment in systemic sclerosis-associated interstitial lung disease trialsDinesh Khanna, Vivek Nagaraja, Chi-Hong Tseng, et al.
Journal of Medicinal Chemistry|January 29, 2000
Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitorsP M O'Brien, D F Ortwine, A G Pavlovsky, et al.
Journal of Medicinal Chemistry|May 29, 1992
Inhibitors of cholesterol biosynthesis. 6. trans-6-[2-(2-N-heteroaryl-3,5-disubstituted- pyrazol-4-yl)ethyl/ethenyl]tetrahydro-4-hydroxy-2H-pyran-2-onesD R Sliskovic, C J Blankley, B R Krause, et al.
Epidemiology and Infection|February 5, 2020
Comparison of routine field epidemiology and whole genome sequencing to identify tuberculosis transmission in a remote settingJ L Guthrie, L Strudwick, B Roberts, et al.
Epidemiology and Infection|August 1, 2019
Whole genome sequencing for improved understanding of Mycobacterium tuberculosis transmission in a remote circumpolar regionJ L Guthrie, L Strudwick, B Roberts, et al.
Journal of Medicinal Chemistry|May 1, 1992
Inhibitors of acyl-CoA:cholesterol acyltransferase. 1. Identification and structure-activity relationships of a novel series of fatty acid anilide hypocholesterolemic agentsB D Roth, C J Blankley, M L Hoefle, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 24, 2012
Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in miceJames L Trevaskis, Peter S Griffin, Carrie Wittmer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2006
Celecoxib decreases Ki-67 proliferative index in active smokersJenny T Mao, Michael C Fishbein, Bradley Adams, et al.
Atherosclerosis|November 1, 1994
Antiatherosclerotic activity of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase in cholesterol-fed rabbits: a biochemical and morphological evaluationT M Bocan, M J Mazur, S B Mueller, et al.
Pageof 94

Showing results (751-760 of 940) with videos related to

Sort By:
Pageof 94
American Journal of Respiratory and Critical Care Medicine|November 4, 2017
Reliability and minimal clinically important differences of forced vital capacity: Results from the Scleroderma Lung Studies (SLS-I and SLS-II)Suzanne Kafaja, Philip J Clements, Holly Wilhalme, et al.
Arthritis Research & Therapy|December 26, 2015
Predictors of lung function decline in scleroderma-related interstitial lung disease based on high-resolution computed tomography: implications for cohort enrichment in systemic sclerosis-associated interstitial lung disease trialsDinesh Khanna, Vivek Nagaraja, Chi-Hong Tseng, et al.
Journal of Medicinal Chemistry|January 29, 2000
Structure-activity relationships and pharmacokinetic analysis for a series of potent, systemically available biphenylsulfonamide matrix metalloproteinase inhibitorsP M O'Brien, D F Ortwine, A G Pavlovsky, et al.
Journal of Medicinal Chemistry|May 29, 1992
Inhibitors of cholesterol biosynthesis. 6. trans-6-[2-(2-N-heteroaryl-3,5-disubstituted- pyrazol-4-yl)ethyl/ethenyl]tetrahydro-4-hydroxy-2H-pyran-2-onesD R Sliskovic, C J Blankley, B R Krause, et al.
Epidemiology and Infection|February 5, 2020
Comparison of routine field epidemiology and whole genome sequencing to identify tuberculosis transmission in a remote settingJ L Guthrie, L Strudwick, B Roberts, et al.
Epidemiology and Infection|August 1, 2019
Whole genome sequencing for improved understanding of Mycobacterium tuberculosis transmission in a remote circumpolar regionJ L Guthrie, L Strudwick, B Roberts, et al.
Journal of Medicinal Chemistry|May 1, 1992
Inhibitors of acyl-CoA:cholesterol acyltransferase. 1. Identification and structure-activity relationships of a novel series of fatty acid anilide hypocholesterolemic agentsB D Roth, C J Blankley, M L Hoefle, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 24, 2012
Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in miceJames L Trevaskis, Peter S Griffin, Carrie Wittmer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2006
Celecoxib decreases Ki-67 proliferative index in active smokersJenny T Mao, Michael C Fishbein, Bradley Adams, et al.
Atherosclerosis|November 1, 1994
Antiatherosclerotic activity of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase in cholesterol-fed rabbits: a biochemical and morphological evaluationT M Bocan, M J Mazur, S B Mueller, et al.
Pageof 94